News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Proneuron Biotechnologies Ltd. (Israel)'s ProCord Receives FDA Orphan Drug Designation



10/19/2005 5:10:08 PM

Proneuron Biotechnologies (www.proneuron.com) announced today that the FDA has granted an orphan drug designation to ProCord, autologous incubated macrophage therapy, to improve the motor and sensory neurological outcome in cases of acute spinal cord injury.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES